02/20/2019
9:41 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 |  |
02/19/2019
9:14 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2019
8:59 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2019
8:29 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2019
5:43 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2019
1:14 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2019
12:58 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2019
12:51 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2019
7:01 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2019
10:35 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2019
10:07 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2019
7:37 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2019
7:36 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2019
7:20 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2019
7:14 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2019
6:44 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/08/2019
7:13 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/08/2019
7:03 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2019
12:39 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2019
7:06 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2019
6:51 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2019
9:55 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2019
7:37 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2019
8:35 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2019
8:04 AM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-T/A
| |
01/22/2019
5:36 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2019
7:17 PM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-T/A
| |
01/15/2019
3:57 PM | GlaxoSmithKline (Reporting)
Principia Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
12:32 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2019
11:20 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2019
10:29 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2019
10:18 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2019
10:03 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2019
9:22 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2019
6:44 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2019
6:19 AM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-T/A
| |
01/11/2019
1:22 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/11/2019
12:28 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2019
4:13 PM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-T/A
| |
01/02/2019
10:35 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2018
11:46 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2018
5:16 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2018
3:58 PM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-T/A
| |
12/17/2018
4:03 PM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-T/A
| |
12/14/2018
7:41 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2018
7:06 AM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-T
| |
12/12/2018
11:31 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2018
4:25 PM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-C
| |
12/04/2018
5:58 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2018
8:55 PM | GlaxoSmithKline (Filed by)
TESARO, Inc. (Subject)
| Form SC TO-C
| |
12/03/2018
9:29 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2018
9:16 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2018
8:07 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/29/2018
10:58 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/29/2018
7:57 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2018
10:12 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/23/2018
5:52 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2018
6:25 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2018
5:32 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2018
7:01 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/02/2018
12:08 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2018
9:10 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2018
1:09 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2018
9:38 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2018
11:41 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2018
6:19 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2018
4:03 PM | ChemoCentryx, Inc. (Issuer)
GlaxoSmithKline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2018
4:02 PM | ChemoCentryx, Inc. (Subject)
GlaxoSmithKline (Filed by)
| Form SC 13D/A
| |
10/18/2018
10:49 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2018
5:05 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2018
12:55 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2018
12:46 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2018
7:00 AM | GlaxoSmithKline (Filed by)
Translate Bio, Inc. (Subject)
| Form SC 13D/A
| |
10/17/2018
6:16 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2018
1:10 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2018
6:02 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2018
5:30 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2018
10:00 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2018
10:25 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2018
11:52 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2018
7:06 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2018
4:18 PM | GlaxoSmithKline (Reporting)
Principia Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2018
3:39 PM | GlaxoSmithKline (Filed by)
Spero Therapeutics, Inc. (Subject)
| Form SC 13D/A
| |
09/18/2018
3:43 PM | ChemoCentryx, Inc. (Subject)
GlaxoSmithKline (Filed by)
| Form SC 13D/A
| |
09/14/2018
5:32 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2018
4:25 PM | GlaxoSmithKline (Reporting)
Principia Biopharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2018
12:32 PM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/10/2018
5:35 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/10/2018
5:30 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2018
8:56 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2018
8:49 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2018
5:44 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2018
11:51 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2018
6:08 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/24/2018
5:58 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2018
5:20 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/10/2018
9:18 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2018
7:12 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2018
5:20 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2018
7:31 AM | GlaxoSmithKline (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
